| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.48B | 53.63B | 53.61B | 50.60B | 55.36B | 49.89B |
| Gross Profit | 8.36B | 8.59B | 8.18B | 6.84B | 7.29B | 7.23B |
| EBITDA | 5.33B | 4.89B | 5.20B | 4.00B | 4.50B | 3.87B |
| Net Income | 1.38B | 1.53B | 1.54B | 546.00M | 977.00M | 1.40B |
Balance Sheet | ||||||
| Total Assets | 67.69B | 70.82B | 67.86B | 69.94B | 67.95B | 66.49B |
| Cash, Cash Equivalents and Short-Term Investments | 5.45B | 5.34B | 5.90B | 6.75B | 6.08B | 7.50B |
| Total Debt | 27.84B | 28.58B | 28.58B | 30.26B | 29.94B | 28.18B |
| Total Liabilities | 47.07B | 46.70B | 46.78B | 50.77B | 50.18B | 49.58B |
| Stockholders Equity | 20.54B | 24.03B | 20.99B | 19.08B | 17.69B | 16.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.00M | 450.00M | 1.40B | -3.15B | -5.03B |
| Operating Cash Flow | 0.00 | 4.40B | 3.30B | 3.40B | 1.70B | -572.00M |
| Investing Cash Flow | 0.00 | -4.60B | -2.55B | -1.93B | -4.59B | -4.50B |
| Financing Cash Flow | 0.00 | -421.00M | -1.86B | -900.00M | 1.42B | 3.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥32.13B | 8.51 | ― | 3.84% | 3.45% | 14.22% | |
68 Neutral | ¥10.50B | 8.65 | ― | 3.23% | 10.90% | 3.72% | |
64 Neutral | ¥27.00B | 11.36 | ― | 4.27% | 2.37% | -16.75% | |
62 Neutral | ¥23.93B | 10.21 | ― | 4.62% | 2.73% | 206.70% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥15.38B | 10.47 | ― | 2.78% | 0.02% | -1.04% | |
53 Neutral | ¥7.20B | 12.53 | ― | 1.35% | -1.83% | 14.37% |